Viewing Study NCT04763408

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 10:57 AM
Ignite Modification Date: 2026-04-22 @ 2:40 PM
Study NCT ID: NCT04763408
Status: COMPLETED
Last Update Posted: 2024-07-18
First Post: 2021-02-17
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Evaluate the Safety and Tolerability of Lenvatinib in Participants With Advanced or Unresectable Hepatocellular Carcinoma
Sponsor: Eisai Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Carcinoma, Hepatocellular View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Lenvatinib View
None Advanced or unresectable carcinoma hepatocellular View
None E7080 View